Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Alment praktiserende læge Kurt Overgård Høegh ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   12.5% 9.4% 11.7% 7.4% 6.9% 7.3% 13.3% 11.2%   Credit score (0-100)   21 28 22 33 33 32 16 22   Credit rating   BB BB BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   82.0 182 442 598 702 389 0.0 0.0   EBITDA   82.0 7.3 442 598 702 1,089 0.0 0.0   EBIT   82.0 7.3 442 598 702 739 0.0 0.0   Pre-tax profit (PTP)   84.0 5.9 426.0 590.4 698.3 611.6 0.0 0.0   Net earnings   65.0 4.6 328.8 458.9 543.9 476.4 0.0 0.0   Pre-tax profit without non-rec. items   84.0 5.9 426 590 698 612 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   115 120 448 807 1,238 1,515 1,065 1,065   Interest-bearing liabilities   0.0 0.0 0.0 3.0 3.0 3.0 0.0 0.0   Balance sheet total (assets)   1,241 1,405 1,989 2,368 2,653 1,658 1,065 1,065   Net Debt   -272 -528 -384 -605 -1,016 -1,655 -1,065 -1,065     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   82.0 182 442 598 702 389 0.0 0.0   Gross profit growth   0.0% 122.4% 142.2% 35.5% 17.3% -44.5% -100.0% 0.0%   Employees   0 1 0 0 0 0 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,241 1,405 1,989 2,368 2,653 1,658 1,065 1,065   Balance sheet change%   0.0% 13.2% 41.6% 19.0% 12.0% -37.5% -35.8% 0.0%   Added value   82.0 7.3 441.8 598.5 702.2 1,089.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 -350 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 4.0% 100.0% 100.0% 100.0% 189.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.3% 0.5% 26.0% 27.5% 28.2% 35.5% 0.0% 0.0%   ROI %   67.9% 5.7% 155.5% 95.1% 69.1% 55.5% 0.0% 0.0%   ROE %   56.5% 3.9% 115.7% 73.1% 53.2% 34.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   9.3% 8.5% 22.5% 34.1% 46.7% 91.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -331.7% -7,259.5% -86.8% -101.1% -144.7% -151.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.4% 0.2% 0.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 540.2% 340.2% 5,133.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.1 1.1 1.3 1.5 1.9 11.5 0.0 0.0   Current Ratio   1.1 1.1 1.3 1.5 1.9 11.5 0.0 0.0   Cash and cash equivalent   272.0 527.9 383.7 608.0 1,019.4 1,658.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   134.0 119.7 448.4 807.3 731.9 639.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 7 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 7 0 0 0 0 0 0   EBIT / employee   0 7 0 0 0 0 0 0   Net earnings / employee   0 5 0 0 0 0 0 0